26 May 2026

strategyland.uk

J Sainsbury PLC (SBRY)

Rank #32 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

J Sainsbury PLC

SBRY.L·Consumer Non-Cyclicals·Market Cap £7.0b

Rank #32 of 100

Data from Excel Model · 100 Stocks Analysed

£3.10

-4.58% YTD

Target: £3.48(+12.0%)

52W: £2.64 - £3.62

Score Analysis

J Sainsbury PLC is ranked #32 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

54/100

Average Score

Liquidity

Weak73/100

Valuation

Fair46/100

Profitability

Excellent10/100

Solvency

Weak92/100

Asset Efficiency

Excellent9/100

Mkt Trading

Fair60/100

Technical

Weak87/100

1. Valuation

Score: 46/100

Is SBRY undervalued compared to its peers and fair value metrics?

5/5

valuation criteria met

✓

FY26e P/E Ratio

12.9xRank 37/100

✓

FY27e P/E Ratio

11.5xRank 35/100

✓

Price-to-Book

1.28xRank 22/100

✓

Price-to-Tangible Book

1.49xRank 21/100

✓

EV/EBITDA

5.9xRank 17/100

Key Valuation Metrics

Current P/E

17.4x

Price-to-Earnings

FY26e P/E

12.9x

Forward estimate

FY27e P/E

11.5x

Forward estimate

P/B Ratio

1.28x

Price-to-Book

P/TBV

1.49x

Price-to-Tangible Book

EV/EBITDA

5.9x

Enterprise Value

FY26e EV/EBITDA

5.5x

Forward estimate

FY27e EV/EBITDA

5.5x

Forward estimate

Analyst Consensus Target

Current Price

£3.10

Consensus Target

£3.48

Potential

+12.0%

Target

Bloomberg Median Target: £3.45

2. Profitability

Score: 10/100

How profitable is SBRY relative to its peers?

2/6

profitability criteria met

✓

TTM Profit Margin

1.2%Rank 10/100

–

Current ROE

6.5%

–

Current ROA

N/A

✓

FY26e EPS

0.27Rank 11/100

–

TTM EPS

0.24

–

Net Income Growth

N/A

Profit Margin

1.2%

ROE

6.5%

FY27e ROE

9.6%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 92/100

How strong is SBRY's balance sheet and financial position?

1/4

solvency criteria met

–

Debt-to-Equity

107.3%

–

Interest Coverage

N/A

✓

Debt/EBITDA

Rank 28Rank 28/100

–

Altman Z-Score

2.19

Key Health Metrics

Quick Ratio

0.24

Below 1.0

Cash Ratio

0.55

Debt/Equity

107%

FCF Margin

0.4%

Altman Z-Score

2.19

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 9/100

How efficiently does SBRY deploy its assets and intellectual capital?

0/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

–

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

N/A

Overall Asset Efficiency Rank

Rank within sector peers#9/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.